Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ICCC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ICCC recently traded at $9.88. Market cap is $89.65M. P/E ratio is -140.91. Revenue is $29.93M.
| Metric | Value |
|---|---|
| Price | $9.88 |
| Market Cap | $89.65M |
| P/E Ratio | -140.91 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.25 |
| 52-Week Low | $3.38 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $29.93M |
| Net Income | $-545.40K |
| Gross Margin | 42.59% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $27.64M | $-1.04M | $-0.12 |
| 2024 | $26.49M | $-2.16M | $-0.26 |
| 2023 | $17.47M | $-5.77M | $-0.75 |
| 2022 | $18.57M | $-4.99M | $-0.32 |
ICCC analyst coverage data. Average price target: $0.00.